Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History APLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics APLT

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Applied Therapeutics Inc

APLT
Current price
0.47 USD +0.03 USD (+6.80%)
Last closed 0.42 USD
ISIN US03828A1016
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 58 626 620 USD
Yield for 12 month -91.07 %
1Y
3Y
5Y
10Y
15Y
APLT
21.11.2021 - 28.11.2021

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It develops AT-001 that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York. Address: 545 Fifth Avenue, New York, NY, United States, 10017

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.63 USD

P/E Ratio

Dividend Yield

Financials APLT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures APLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+455 000 USD

Last Year

+9 993 000 USD

Current Quarter

-1 000 USD

Last Quarter

Current Year

+30 000 USD

Last Year

+9 640 000 USD

Current Quarter

-215 000 USD

Last Quarter

EBITDA -108 730 752 USD
Operating Margin TTM -41 030.57 %
Price to Earnings
Return On Assets TTM -65.30 %
PEG Ratio
Return On Equity TTM -83.71 %
Wall Street Target Price 5.63 USD
Revenue TTM 265 000 USD
Book Value 0.26 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -98.20 %
Dividend Yield
Gross Profit TTM -44 099 000 USD
Earnings per share -0.24 USD
Diluted Eps TTM -0.24 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation APLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 29.66
Price Sales TTM 221.23
Enterprise Value EBITDA -9.71
Price Book MRQ 1.53

Technical Indicators APLT

For 52 Weeks

0.30 USD 10.62 USD
50 Day MA 0.39 USD
Shares Short Prior Month 21 327 659
200 Day MA 2.60 USD
Short Ratio 8.79
Shares Short 18 077 667
Short Percent 15.17 %